Company

DK MedTech

鼎科医疗

DK MedTech (鼎科医疗) is a cardiovascular interventional device company backed by Qiming Venture Partners, which features it regularly in its portfolio updates . Its core products sit in the balloon-catheter space: the DK Score® coronary scoring balloon, which debuted in the Malaysian market in 2025 , and the DKutting™ high-pressure scoring balloon plus DKaptain™ high-pressure balloon, both launched into the US market that same year . In mid-2025 it also struck a US market strategic partnership with kidney-health company Mozarc Medical , and it has appeared alongside other Qiming healthcare names on lists such as VBData's Future Healthcare 100 . Elsewhere's corpus doesn't cover its founding details, team, or funding history — the material is Qiming's own portfolio-news roundups.

AI-generated — may contain errors, please verify.

DK MedTechCompany
鼎科医疗
渲染中…
Mentioned in 12 articles

Coverage